Immutep Ltd. Files SEC Form 6-K

Ticker: PRRUF · Form: 6-K · Filed: Aug 15, 2024 · CIK: 1506184

Immutep Ltd 6-K Filing Summary
FieldDetail
CompanyImmutep Ltd (PRRUF)
Form Type6-K
Filed DateAug 15, 2024
Risk Levellow
Pages1
Reading Time1 min
Sentimentneutral

Sentiment: neutral

Topics: sec-filing, regulatory-update, foreign-private-issuer

Related Tickers: IMMU

TL;DR

IMMU filed a 6-K, just routine paperwork, no new news.

AI Summary

Immutep Ltd. announced on August 14, 2024, that it has filed a Form 6-K with the SEC. This filing is a report of a foreign private issuer and does not contain new financial results or material events beyond what has already been disclosed. The company previously operated under the name Prima BioMed Ltd until November 19, 2010.

Why It Matters

This filing indicates Immutep is fulfilling its reporting obligations as a foreign private issuer, providing transparency to investors about its regulatory compliance.

Risk Assessment

Risk Level: low — The filing is a standard procedural report for a foreign private issuer and does not contain new material information or financial updates.

Key Players & Entities

  • Immutep Ltd. (company) — Registrant
  • Prima BioMed Ltd (company) — Former company name
  • August 14, 2024 (date) — Filing date
  • November 19, 2010 (date) — Date of name change
  • 001-35428 (other) — SEC File Number

FAQ

What is the purpose of this Form 6-K filing?

The Form 6-K is a report of a foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to furnish information to the SEC.

Does this filing contain new financial results for Immutep Ltd.?

No, the filing indicates it is a report of a foreign private issuer and does not appear to contain new financial results or material events beyond what has already been disclosed.

What was Immutep Ltd.'s former company name?

Immutep Ltd.'s former company name was Prima BioMed Ltd.

When did Immutep Ltd. change its name from Prima BioMed Ltd?

The date of the name change from Prima BioMed Ltd to Immutep Ltd was November 19, 2010.

What is the SEC file number for Immutep Ltd.?

The SEC file number for Immutep Ltd. is 001-35428.

Filing Stats: 264 words · 1 min read · ~1 pages · Grade level 17.1 · Accepted 2024-08-14 20:16:25

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Dated: August 14, 2024 IMMUTEP LIMITED By: /s/ Marc Voigt Name: Marc Voigt Title: Chief Executive Officer

View Full Filing

View this 6-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.